September 24, 2019
Levi & Korsinsky LLP and Bernstein Litowitz Berger & Grossmann LLP each asked a federal judge Monday for the lead role in a pair of stock-drop suits claiming Massachusetts-based Karyopharm Therapeutics Inc. misled investors about clinical trials relating to a blood cancer treatment.